Latest carcinoid syndrome Stories
-- Lexicon eligible for an additional $5 million in up-front and pre-commercial milestone payments for Canadian rights, plus royalties and sales milestones under original agreement --
Top-Line Results Expected in the 3rd Quarter of 2015 THE WOODLANDS, Texas, March 9, 2015 /PRNewswire/ -- Lexicon
THE WOODLANDS, Texas, Feb.
Focus on the Completion of Phase 3 Clinical Trials and Commercial Preparations for Telotristat Etiprate in Carcinoid Syndrome THE WOODLANDS, Texas, Nov.
-- Telotristat etiprate, a Phase 3 compound for the treatment of carcinoid syndrome PARIS and THE WOODLANDS, Texas, Oct.
Conference Call and Webcast at 11:00 a.m. Eastern Time THE WOODLANDS, Texas, Feb.
DUBLIN, January 29, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/q8l6jf/lexicons) has announced the addition of the "Lexicon's
New Phase in Company Evolution from Genetics to Therapies THE WOODLANDS, Texas, Jan.
- A person in a secondary role, specifically the second most important character (after the protagonist).